Sponsored
released by
Lighthouse Instruments
04.22.24
Drug Discovery And Development
Financial Analysis
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Collaborations & Alliances | Drug Discovery
Fujifilm & Predictive Oncology Tackle Protein Interference
Enter a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.04.25.24
-
Breaking News | Drug Development
Regeneron & Mammoth Partner on CRISPR Therapies
Aim to create disease-modifying medicines that can be delivered to tissues beyond the liver, to which most gene editing treatments are currently limited.04.25.24
-
Breaking News | Clinical Trials | CRO News | Information Technology
Parexel, Palantir Expand AI Alliance
Aims to accelerate clinical data delivery and power clinical outcomes.04.25.24
-
Breaking News | Drug Development | Promotions & Moves
Ascend Taps Scott Law as COO
Law brings more than 30 years of global pharmaceutical experience.04.25.24
-
Breaking News | Clinical Trials | Collaborations & Alliances | Scale-up/Technology Transfer
FibroBiologics Discusses Opportunities to Work with Charles River
Anticipates a master services agreement for the development and manufacture of FibroBiologics’ fibroblast-based spheroid.04.25.24
-
Breaking News | Drug Development | Industry News
Kühne Holding AG Agrees to Acquire Aenova Group
Enlarges its investment portfolio to include healthcare and pharmaceutical assets.04.24.24
-
Breaking News | Collaborations & Alliances | Drug Development
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
Collaboration will combine the drug discovery, clinical development and data science expertise from Johnson & Johnson with BigHat’s AI/ML platform.04.24.24
-
Breaking News | Collaborations & Alliances | Drug Development
Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs
Aim to revolutionize transdermal release of ‘difficult-to-formulate’ compounds targeting the endocannabinoid system.04.24.24
-
Breaking News | Drug Development | Trials & Filings
Sanofi’s Rilzabrutinib Meets Primary Endpoint in ITP
Demonstrates significantly higher proportion of patients receiving rilzabrutinib achieved primary endpoint of durable platelet response versus placebo.04.23.24
-
Breaking News | Collaborations & Alliances | Drug Development
Tharimmune Announces Option for Novel HER2/HER3 Cancer Therapies
Obtains rights from Washington University to develop and incorporate human HER2 directed antibodies.04.23.24
-
Breaking News | Clinical Trials | Drug Development | Promotions & Moves
Calluna Names Senior Vice President of Clinical Operations & Pharmacovigilance
Margrethe Sørgaard offers 25 years’ experience in leading positions in clinical development and operation, medical affairs and drug safety/pharmacovigilance.04.23.24
-
Clinical Trials | Supply Chain
Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.04.23.24
-
Injectables | Laboratory Testing
![[WEBINAR] Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing](https://images.rodpub.com/images/305/150_thumb.jpg)
[WEBINAR] Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing
This webinar will cover how headspace methods are developed and validated for a variety of product-container configurations including pre-filled syringes.
-
Breaking News | Drug Development | Industry News
Lexeo Enters License Agreement for Friedreich Ataxia Treatment
Aims to expedite development of investigational gene therapy candidate LX2006 for the treatment of FA cardiomyopathy.04.22.24
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development
BioArctic, Eisai Ink Research Agreement for BAN2802 in AD
To evaluate potential new treatment combining BioArctic's BrainTransporter technology with an undisclosed Alzheimer drug candidate.04.22.24
-
Clinical Trial Materials | Clinical Trials | Supply Chain
![[WEBINAR] Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model](https://images.rodpub.com/images/305/148_thumb.jpg)
[WEBINAR] Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research
Aim to discover and develop small molecules for the treatment of rare neurological diseases.04.22.24
-
Breaking News | Collaborations & Alliances | Drug Discovery
Takeda and Astellas Agree to Establish Joint Venture Company
New joint venture aims to cover the entire drug discovery process, spanning early drug discovery research through the inception of drug discovery startups.04.22.24
-
Breaking News | Drug Development | Promotions & Moves
SystImmune Names New CEO
Taps former Bristol Myers Squibb exec with 20 years’ experience in the biopharmaceutical industry.04.22.24
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
RevolKa and La Jolla Institute Partner to Create Antigens for Next-Gen Vaccines
Aim to address unmet medical needs in infectious diseases.04.19.24
